Product NDC: | 68016-193 |
Proprietary Name: | Loperamide HCl |
Non Proprietary Name: | LOPERAMIDE HYDROCHLORIDE |
Active Ingredient(s): | 2 mg/1 & nbsp; LOPERAMIDE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68016-193 |
Labeler Name: | Chain Drug Consortium, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA021855 |
Marketing Category: | NDA |
Start Marketing Date: | 20121204 |
Package NDC: | 68016-193-12 |
Package Description: | 2 BLISTER PACK in 1 BOX (68016-193-12) > 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
NDC Code | 68016-193-12 |
Proprietary Name | Loperamide HCl |
Package Description | 2 BLISTER PACK in 1 BOX (68016-193-12) > 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
Product NDC | 68016-193 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | LOPERAMIDE HYDROCHLORIDE |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20121204 |
Marketing Category Name | NDA |
Labeler Name | Chain Drug Consortium, LLC |
Substance Name | LOPERAMIDE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes |